Incident Noninfectious Uveitis Risk after Immune Checkpoint Inhibitor Treatment

Ophthalmology. 2024 Mar 22:S0161-6420(24)00198-2. doi: 10.1016/j.ophtha.2024.03.017. Online ahead of print.

Authors

Myung Soo Chang¹, Seung Won Lee², Sunyeup Kim³, Christopher Seungkyu Lee¹, Suk Ho Byeon¹, Sung Soo Kim¹, Yong Joon Kim⁴

Affiliations

¹ Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.
² Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, Korea.
³ Department of Medical AI, Sungkyunkwan University School of Medicine, Suwon, Korea.
⁴ Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea. Electronic address: kyjcolor@naver.com.

PMID: 38522600
DOI: 10.1016/j.ophtha.2024.03.017

No abstract available

Keywords: immune checkpoint inhibitor; skin melanoma; uveitis.